Related Experiment Video

Updated: Apr 20, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

959

Firstline treatment for chronic phase chronic myeloid leukemia patients should be based on a holistic approach

Massimo Breccia1, Giuliana Alimena

  • 1Department of Cellular Biotechnologies and Hematology, Sapienza University, Via Benevento 6, 00161 Rome, Italy.

Expert Review of Hematology
|November 29, 2014
PubMed

Insights

Selecting the best treatment for chronic myeloid leukemia (CML) requires a holistic approach. Considering patient-specific factors like comorbidities and lifestyle ensures optimal therapeutic strategies for chronic phase CML.

Area of Science:

  • Hematology
  • Oncology
  • Pharmacology

Background:

  • New potent drugs for chronic phase chronic myeloid leukemia (CML) are available, necessitating careful physician selection.
  • Optimal prognostic factors for guiding drug selection in CML remain under discussion.

Discussion:

  • A holistic approach, integrating patient-specific variables, is proposed for CML treatment selection.
  • Factors include comorbidities, age, concomitant medications, lifestyle, and patient expectations.

Key Insights:

  • Individualized therapeutic strategies are crucial for chronic phase CML patients.
  • A comprehensive patient assessment beyond traditional prognostic factors is recommended.

Outlook:

  • This holistic strategy may improve treatment outcomes for chronic myeloid leukemia.
  • Further research should validate the impact of holistic patient assessment in CML management.

Keywords:
chronic myeloid leukemiaholistic approachtherapy

More Related Videos

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

14.9K
Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

884

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
5.0K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K